Loading organizations...
Based in Palm Beach, Florida, DeLorean Artificial Intelligence develops predictive artificial intelligence systems that analyze medical records to forecast disease onset and progression for various healthcare providers and insurers. The company operates an AI-as-a-service business model to manage chronic conditions like diabetes and kidney disease, while also expanding its proprietary technology into the sales and financial technology sectors across the global market. To scale its corporate operations, DeLorean Artificial Intelligence has raised $7.55 million in Series A funding and plans to expand its current workforce by adding 10 to 20 new employees. The enterprise generates revenues projected to exceed $35 million annually while serving major clients and advisory partners that include Fortune 500 companies, the United Nations, and the World Health Organization. The organization was officially founded in 2019 by chief executive officer Severence MacLaughlin.
DeLorean Artificial Intelligence has raised $7.5M across 1 funding round.
DeLorean Artificial Intelligence has raised $7.5M in total across 1 funding round.
DeLorean Artificial Intelligence has raised $7.5M in total across 1 funding round.
DeLorean Artificial Intelligence's investors include Sopris Venture Capital, James Chow, Pinta Capital Partners.
DeLorean Artificial Intelligence has raised $7.5M across 1 funding round. Most recently, it raised $7.5M Series A in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 13, 2023 | $7.5M Series A | Sopris Venture Capital | James Chow, Pinta Capital Partners | Announced |
